Skip to content
Ranked #207
Kin Meds

Compounded and brand-name GLP-1 plus a longevity stack on one platform.

semaglutide
$149/mobrand-name
tirzepatide
$149/mobrand-name

FDAWarning letter issued to Kin Meds in February 2026. See the FDA warning-letter database.

Before enrolling

Legal entity name and state of incorporation not publicly disclosed

vs
Ranked #199Desk pick
MedLeanRx

Texas-only compounded semaglutide at $149/mo with a brand Wegovy and Zepbound pathway.

semaglutide
$149/mopromo rate
tirzepatide
From $269/molowest dose rung
Before enrolling

Texas only — not available in the other 49 states

Our review of MedLeanRx gives it 69/100 (C), while our review of Kin Meds gives it 68/100 (C). The score breakdown shows where each provider does better.

Desk Score, dimension by dimension

Same six measured dimensions for both. The green bar marks the stronger score. See the methodology.

Kin Meds

68/100

C

Overall

MedLeanRx

69/100

C

Price transparency

78
78

State access

24
42

Molecule range

97
95

Onboarding speed

72
52

Support responsiveness

78
70

Licensing & trust

57
74

The spec sheet

Check the billing terms before comparing the figures. Our guide to paying for GLP-1 care without insurance explains how medication charges, membership fees and prepaid terms affect what you owe.

FieldKin MedsMedLeanRx
Semaglutide$149/mobrand-name
Full plan terms

$149/mo (brand Wegovy)

$149/mopromo rate
Full plan terms

$149/mo (starting dose, promotional rate, compounded)

Tirzepatide$149/mobrand-name
Full plan terms

$149/mo (brand Zepbound)

From $269/molowest dose rung
Full plan terms

$269/mo (starting dose, compounded)

CoverageNot confirmed for Kin Meds.1 state
Brand-nameBrand-name option listedBrand-name option listed
Oral optionOral option listedOral option listed
Best forCompounded and brand-name GLP-1 plus a longevity stack on one platform.Texas-only compounded semaglutide at $149/mo with a brand Wegovy and Zepbound pathway.
Desk Score68/100C69/100C

The verdict

Desk pick — MedLeanRx

MedLeanRx has the higher Desk Score, but Kin Meds may be a better fit if it covers your state, offers the prescribed product or has billing terms that work better for you.

Choose Kin Meds if…

Compounded and brand-name GLP-1 plus a longevity stack on one platform.

$149/mo (brand-name) sema · $149/mo (brand-name) tirz

FDAWarning letter issued to Kin Meds in February 2026. See the FDA warning-letter database.

Choose MedLeanRx if…

Texas-only compounded semaglutide at $149/mo with a brand Wegovy and Zepbound pathway.

$149/mo (promo rate) sema · From $269/mo (lowest dose rung) tirz · 1 state

Assume any provider we list may compensate us. We may earn a referral commission at no extra cost to you, and compensation does not change the Desk Score.

Also here

CoreAge Rx leads the whole ranking at 94/100

Whichever of these two you lean toward, our #1-rated provider outscores them both. Both compounded injections with dose-independent advertised rates. The $79 and $129 monthly equivalents require a year paid in full; confirm the total charge and refund terms.

More head-to-heads

Or see the full comparison hub and the complete ranking.

Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.